Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-establishes-asias-first-microbiota-transplantation-and-research-centre-hope-for-new-strategies-in-disease-prevention-and-cure
https://www.med.cuhk.edu.hk/press-releases/cuhk-establishes-asias-first-microbiota-transplantation-and-research-centre-hope-for-new-strategies-in-disease-prevention-and-cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

The Faculty of Medicine at The Chinese University of Hong Kong (CUHK) has established Asia’s first and Hong Kong’s only microbiota transplantation and research centre to unravel the role of the gut microbiota in human health, and to develop novel strategies for disease prevention and intervention. With successful experience in using microbiota transplantation to treat a number of life threatening conditions, experts from the Faculty are now investigating its potential to treat other conditions including obesity. 

 

Gut Microbiota May Hold the Key to Curing Many Diseases  

Professor Francis KL CHAN, Dean of the Faculty of Medicine and Choh-Ming Li Professor of Medicine and Therapeutics at CUHK said, “Recent evidence suggests that imbalance in the gut microbiota can lead to many human diseases. Although microbiota-based therapeutics appears promising, the science behind this is still in its infancy. The Faculty of Medicine has been the pioneer in Asia in gut microbiota research. Not only have we published our work in top tier international journals, we have also successfully used microbiota transplantation to recover patients from life-threatening gastrointestinal diseases. Having set up Asia’s first and only microbiota transplantation and research centre in Hong Kong, we will now expand research in microbiota transplantation to other conditions such as obesity and metabolic syndrome. Our goal is to preserve and improve human health through the restoration of microbiota.” 

 

Safety is Our Priority – Rigorous Screening is Required for Every Donor  

Professor Paul Kay Sheung CHAN, Chairman of the Department of Microbiology, Faculty of Medicine at CUHK explained, “The Faculty established the gut microbiota biobank, the first of its kind, in March 2016 to provide quality-assured frozen microbiota solution for microbiota transplantation. Safety, optimisation, and viability preservation are the three key elements of our gut microbiota biobank. Our donors are required to undergo rigorous assessment and investigations by an integrated team of microbiologists, gastroenterologists and pathologists to ensure their stools are suitable for microbiota transplantation. The health requirements on stool donors are stricter than those for blood or organ donors.”  

 

“To date, the facility has supported over 80 microbiota transplantations. Not only have we saved numerous patients with life-threatening gastrointestinal diseases using this approach, it has also advanced our knowledge on this new treatment option.”  

 

Microbiota Transplantation as a Potential Treatment for Obesity

The team is working on a pilot study to investigate the use of microbiota transplantation to treat obese patients with type II diabetes mellitus. There is an epidemic of obesity worldwide. In Hong Kong, four out of ten adults are either overweight or obese.

 

Professor Siew Chien NG, Professor of the Department of Medicine and Therapeutics, Faculty of Medicine at CUHK said, “Although obese patients with type II diabetes mellitus may be treated with lifestyle changes, medications or bariatric surgery, these treatments are not widely acceptable, and they are limited by incomplete resolution of the disease, high cost and surgical risk. There is a real need for a more promising and safe approach to treating obesity.”  

 

“We select lean individuals with a BMI < 23kg/m2 as donors for microbiota transplantation. We investigate weight reduction and improvement in sugar control in obese patients with type II diabetes mellitus after microbiota transplantation.”  

 

“So far we have treated over 20 subjects; several have shown promising weight loss over 6 months. The most substantial weight loss we have seen was 12 kg. We are encouraged by this and will continue to monitor our subjects for up to one year,” Professor NG added.

 

The Faculty of Medicine at CUHK established Asia’s first microbiota transplantation and research centre to unravel the role of the gut microbiota in human health. The Centre is currently investigating if microbiota transplantation can be a potential treatment for obesity. (From left) Professor Paul Kay Sheung CHAN, Chairman of the Department of Microbiology; Professor Siew Chien NG, Professor of the Department of Medicine and Therapeutics and Professor Francis KL CHAN, Dean of the Faculty of Medicine and Choh-Ming Li Professor of Medicine and Therapeutics at CUHK.

The Faculty of Medicine at CUHK established Asia’s first microbiota transplantation and research centre to unravel the role of the gut microbiota in human health. The Centre is currently investigating if microbiota transplantation can be a potential treatment for obesity. (From left) Professor Paul Kay Sheung CHAN, Chairman of the Department of Microbiology; Professor Siew Chien NG, Professor of the Department of Medicine and Therapeutics and Professor Francis KL CHAN, Dean of the Faculty of Medicine and Choh-Ming Li Professor of Medicine and Therapeutics at CUHK.

Professor Francis CHAN says the Faculty has completed over 80 cases of microbiota transplantation since 2016, including successful cases to recover patients from life-threatening gastrointestinal diseases.

Professor Francis CHAN says the Faculty has completed over 80 cases of microbiota transplantation since 2016, including successful cases to recover patients from life-threatening gastrointestinal diseases.

Professor Paul CHAN emphasizes that the health requirements on stool donors are stricter than those for blood or organ donors.

Professor Paul CHAN emphasizes that the health requirements on stool donors are stricter than those for blood or organ donors.

Professor Siew NG reveals that the team has treated over 20 subjects with obesity and type II diabetes. Several have shown promising weight loss over 6 months after microbiota transplantation. The most substantial weight loss seen was 12 kg.

Professor Siew NG reveals that the team has treated over 20 subjects with obesity and type II diabetes. Several have shown promising weight loss over 6 months after microbiota transplantation. The most substantial weight loss seen was 12 kg.

More Press Releases

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
CU Medicine’s large-scale mother-baby study finds altered gut microbiome  in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

CU Medicine’s large-scale mother-baby study finds altered gut microbiome in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

Research
CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders  Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

Research
Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Awards and honors
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
Professor Francis Chan receives Guanghua Engineering Science and Technology Award

Professor Francis Chan receives Guanghua Engineering Science and Technology Award

Awards and honors
CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

Awards and honors
CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong  to be selected as a New Cornerstone Investigator

CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong to be selected as a New Cornerstone Investigator

Awards and honors
CUHK receives HK$30 million donation from Mr Li Ka-shing to further enhance artificial intelligence in medical education

CUHK receives HK$30 million donation from Mr Li Ka-shing to further enhance artificial intelligence in medical education

Donation
CU Medicine establishes an internationally accredited biobank:  A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

CU Medicine establishes an internationally accredited biobank: A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

Milestone
Inaugural Croucher Professorship in Medical Sciences lecture by Professor Siew Ng:   A Magical Pursuit

Inaugural Croucher Professorship in Medical Sciences lecture by Professor Siew Ng: A Magical Pursuit

Awards and honors
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
中大醫學院就行政長官今日(10月19日)發表2022施政報告的回應 (Chinese Version Only)

中大醫學院就行政長官今日(10月19日)發表2022施政報告的回應 (Chinese Version Only)

Response
CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

Donation
中大醫學院就2022-23財政預算案的回應 (Chinese Version Only)

中大醫學院就2022-23財政預算案的回應 (Chinese Version Only)

Response
Clarification -- 中大醫學院澄清啟事 (Chinese Version Only)

Clarification -- 中大醫學院澄清啟事 (Chinese Version Only)

Response
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

Research
CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

Health Campaign
CUHK Reveals the Key to a Successful HPV Vaccination Programme

CUHK Reveals the Key to a Successful HPV Vaccination Programme

Research
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

Education
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research
CUHK Research Reveals New Influenza Vaccine Offers More Effective Control over Influenza in Hong Kong

CUHK Research Reveals New Influenza Vaccine Offers More Effective Control over Influenza in Hong Kong

Research
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

Research
CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

Clinical service
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service
CUHK Research Findings on Severe Human Swine Flu in Hong Kong

CUHK Research Findings on Severe Human Swine Flu in Hong Kong

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.